XML 24 R11.htm IDEA: XBRL DOCUMENT v3.23.1
Revenue from Contracts with Customers
3 Months Ended
Mar. 31, 2023
Revenue from Contract with Customer [Abstract]  
Revenue from Contracts with Customers

3.   Revenue from Contracts with Customers. We recognize revenue when a customer obtains control of promised goods. The amount of revenue recognized reflects the consideration we expect to receive in exchange for these goods. Our revenue recognition policies have not changed from those disclosed in Note 1 to our consolidated financial statements in Item 8 of the 2022 Annual Report on Form 10-K.

Disaggregation of Revenue

Our revenue is disaggregated based on reporting segment, product category and geographical region. We design, develop, manufacture and market medical products for interventional and diagnostic procedures. For financial reporting purposes, we report our operations in two operating segments: cardiovascular and endoscopy. Our cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer (“OEM”). Within these product categories, we sell a variety of products, including cardiology and radiology devices (which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases), as well as embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, breast cancer localization and guidance, biopsy, and interventional oncology and spine devices. Our endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors.

The following tables present revenue from contracts with customers by reporting segment, product category and geographical region for the three-month periods ended March 31, 2023 and 2022 (in thousands):

Three Months Ended

Three Months Ended

March 31, 2023

March 31, 2022

    

United States

    

International

    

Total

    

United States

    

International

    

Total

Cardiovascular

 

  

 

 

  

 

  

 

  

 

  

Peripheral Intervention

$

68,667

$

45,116

$

113,783

$

62,100

43,673

$

105,773

Cardiac Intervention

 

34,305

51,023

 

85,328

 

28,549

52,938

 

81,487

Custom Procedural Solutions

 

26,799

20,902

 

47,701

 

26,555

19,707

 

46,262

OEM

 

32,564

8,600

 

41,164

 

27,796

5,618

 

33,414

Total

 

162,335

125,641

 

287,976

 

145,000

 

121,936

 

266,936

 

Endoscopy

Endoscopy Devices

 

9,025

 

564

 

9,589

 

7,992

487

 

8,479

Total

$

171,360

$

126,205

$

297,565

$

152,992

$

122,423

$

275,415